Filing Details
- Accession Number:
- 0001415889-24-010452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-05 18:15:49
- Reporting Period:
- 2024-04-03
- Accepted Time:
- 2024-04-05 18:15:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1192448 | Glaukos Corp | GKOS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1705850 | E Joseph Gilliam | C/O Glaukos Corporation One Glaukos Way Aliso Viejo CA 92656 | President & Coo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-04-03 | 200 | $55.18 | 102,045 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-04-03 | 200 | $96.61 | 101,845 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2024-04-04 | 200 | $55.18 | 102,045 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-04-04 | 200 | $96.57 | 101,845 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-03 | 200 | $0.00 | 200 | $55.18 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2024-04-04 | 200 | $0.00 | 200 | $55.18 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
43,396 | 2032-03-24 | No | 4 | M | Direct | |
43,196 | 2032-03-24 | No | 4 | M | Direct |
Footnotes
- Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
- The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.
- The option was granted by the Issuer on March 24, 2022 and vests upon the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.